{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:44:30Z","timestamp":1761061470890},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T00:00:00Z","timestamp":1627344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T00:00:00Z","timestamp":1627344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Osteoarthritis (OA) is a chronic degenerative disease that suppresses middle-aged and older people worldwide. Silent information regulator 1(SIRT-1) is associated with several age-related diseases, such as cardiovascular diseases, neurodegenerative diseases and tumors, etc. The protective role of SIRT-1 in bone and joint diseases has become increasingly well known.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To explore the relationship between SIRT-1 and its related factors in OA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Fresh tibial plateau specimens were collected from 30 patients with knee OA who underwent total knee arthroplasty. According to the results of Safranin O Fast Green Staining, hematoxylin\u2013eosin staining and the OARSI grade developed by the International Association for the Study of Osteoarthropathy, the specimens were divided into the mild group, moderate group and severe group, and the damage of cartilage was evaluated. SIRT-1 protein levels in cartilage samples were analyzed by immunohistochemistry. Then, take 60 8-week-old female C57BL\/6\u00a0J mice and apply the Destabilization of the medial meniscus (DMM) to induce OA. Mice were randomly divided into normal group (sham), model group (model), and post-modeling drug administration group (srt), and each group was further divided into 2\u00a0weeks after modeling (2\u00a0W) and 8\u00a0weeks after modeling (8\u00a0W) according to the time after surgery. The degenerative degree of a knee joint in mouse knee cartilage samples was evaluated using Safranin O Fast Green Staining and OARSI grade. Immunohistochemical techniques assessed the protein levels of SIRT-1, \u03b2-catenin, LEF-1, MMP-13 and Collagen II in cartilage samples. The protein levels of \u03b2-catenin, LEF-1 and MMP-13 in the samples were assessed by the immunohistofluorescence technique. The mRNA expression of SIRT-1 and LEF-1 in mouse cartilage samples was evaluated by real-time quantitative polymerase chain reaction (qPCR).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In the human cartilage samples, according to the results of Safranin O Fast Green Staining, compared with the mild group, the moderate group and the severe group showed damage cartilage layer structure, the number of chondrocytes decreased, the cell hypertrophic, the cartilage surface discontinuous, and the OARSI grade increased. The severe group had severe cartilage injury and the highest OARSI grade. In the mice cartilage samples, according to immunohistochemical analysis, the protein levels of \u03b2-catenin, LEF-1 and MMP-13 in cartilage specimens of model 2\u00a0W and model 8\u00a0W groups were significantly increased than the sham 2\u00a0W and sham 8\u00a0W groups. The protein levels of SIRT-1 and Collagen II were significantly decreased (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05), the results of srt 2\u00a0W and srt 8\u00a0W groups were between the sham group and the model group. According to immunofluorescence analysis, the protein levels of \u03b2-catenin, LEF-1 and MMP-13 in model 2\u00a0W and model 8\u00a0W groups were significantly increased than sham 2\u00a0W and sham 8\u00a0W groups. The results of srt 2w and srt 8w groups were between the sham group and the model group. According to the real-time qPCR results: Compared with sham 2\u00a0W and sham 8\u00a0W groups, the mRNA expression of SIRT-1 in model 2\u00a0W and model 8\u00a0W groups was significantly decreased, while the mRNA expression of LEF-1 was significantly increased. In contrast, the results of srt 2\u00a0W and srt 8\u00a0W groups were between the sham group and the model group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>SRT-1720, as a specific activator of SIRT-1, does increase the protein level of SIRT-1. SIRT-1 may play a protective role in cartilage by regulating the expression of LEF-1 and related inflammatory factors in OA.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12891-021-04516-x","type":"journal-article","created":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T19:02:59Z","timestamp":1627412579000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The protective mechanism of SIRT1 on cartilage through regulation of LEF-1"],"prefix":"10.1186","volume":"22","author":[{"given":"Xueyu","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gangning","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqiang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qunhua","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,27]]},"reference":[{"issue":"9","key":"4516_CR1","first-page":"1461","volume":"56","author":"TH Gle","year":"2017","unstructured":"Gle TH, Geurts J. What drives osteoarthritis\u2014synovial versus subchondral bone pathology. Rheumatology. 2017;56(9):1461\u201371.","journal-title":"Rheumatology"},{"issue":"2","key":"4516_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.semcdb.2016.07.013","volume":"62","author":"DA Correa","year":"2017","unstructured":"Correa DA, Steven L. Articular cartilage repair: current needs, methods and research directions. Semin Cell Dev Biol. 2017;62(2):67\u201377.","journal-title":"Semin Cell Dev Biol"},{"key":"4516_CR3","doi-asserted-by":"crossref","unstructured":"Richardson JB, Bhosale AM. Articular cartilage: structure, injuries and review of management. Br Med Bull. 2008;87(1):77\u201395.","DOI":"10.1093\/bmb\/ldn025"},{"issue":"1","key":"4516_CR4","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1749-6632.2009.05240.x","volume":"1192","author":"MBG Goldring","year":"2010","unstructured":"Goldring MBG. Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Ann N Y Acad Sci. 2010;1192(1):230\u20137.","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"4516_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11926-016-0602-z","volume":"18","author":"LR Carpio","year":"2016","unstructured":"Carpio LR, Westendorf JJ. Histone deacetylases in cartilage homeostasis and osteoarthritis. Curr Rheumatol Rep. 2016;18(8):1\u20139.","journal-title":"Curr Rheumatol Rep"},{"key":"4516_CR6","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.bone.2013.10.020","volume":"59","author":"A Delalandre","year":"2014","unstructured":"Delalandre A, Denis \u00c9C. Low sirtuin 1 levels in human osteoarthritis subchondral osteoblasts lead to abnormal sclerostin expression which decreases Wnt\/\u03b2-catenin activity. Bone. 2014;59:28\u201336.","journal-title":"Bone"},{"key":"4516_CR7","doi-asserted-by":"crossref","unstructured":"Sasaki M, Takayama T, Hiroshi. The overexpression of SIRT1 inhibited osteoarthritic gene expression changes induced by interleukin-1\u03b2 in human chondrocytes. J Orthop Res. 2013;31(4):531\u20137.","DOI":"10.1002\/jor.22268"},{"issue":"6","key":"4516_CR8","first-page":"1389","volume":"7","author":"Santiago","year":"2017","unstructured":"Santiago, Daniels L, Wang G. Wnt signaling pathway protein LEF1 in cancer, as a biomarker for prognosis and a target for treatment. Am J Cancer Res. 2017;7(6):1389\u2013406.","journal-title":"Am J Cancer Res"},{"issue":"9610","key":"4516_CR9","doi-asserted-by":"publisher","first-page":"5522","DOI":"10.1073\/pnas.96.10.5522","volume":"10","author":"M Shtutman","year":"1999","unstructured":"Shtutman M, Simcha JZI. The cyclin D1 gene is a target of the beta-catenin\/LEF-1 pathway. Proc Natl Acad Sci. 1999;10(9610):5522\u20137.","journal-title":"Proc Natl Acad Sci"},{"issue":"5382","key":"4516_CR10","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1126\/science.281.5382.1509","volume":"281","author":"T He","year":"1998","unstructured":"He T, Carlo ABS. Identification of c-MYC as a target of the APC pathway. Science. 1998;281(5382):1509\u201312.","journal-title":"Science"},{"issue":"1","key":"4516_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-9-159","volume":"9","author":"L Arce","year":"2009","unstructured":"Arce L, Pate KT. Groucho binds two conserved regions of LEF-1 for HDAC-dependent repression. BMC Cancer. 2009;9(1):1\u201314.","journal-title":"BMC Cancer"},{"issue":"7","key":"4516_CR12","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.1096\/fj.201601253R","volume":"31","author":"JLEJ Elayyan","year":"2017","unstructured":"Elayyan JLEJ. LEF1-mediated MMP13 gene expression is repressed by SIRT1 in human chondrocytes. FASEB J. 2017;31(7):3116\u201325.","journal-title":"FASEB J"},{"key":"4516_CR13","doi-asserted-by":"crossref","unstructured":"Glasson SS, Morris SBT. The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129\/SvEv mouse. Osteoarthr Cartilage. 2007;15(9):1061\u20139.","DOI":"10.1016\/j.joca.2007.03.006"},{"issue":"3","key":"4516_CR14","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1302\/2046-3758.73.BJR-2017-0227.R1","volume":"7","author":"K Nishida","year":"2018","unstructured":"Nishida K, Matsushita T, Takayama K. Intraperitoneal injection of the sIRT1 activator sRT1720 attenuates the progression of experimental osteoarthritis in mice. Bone Joint Res. 2018;7(3):252\u201362.","journal-title":"Bone Joint Res"},{"issue":"1","key":"4516_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.joca.2005.07.014","volume":"14","author":"KPH Pritzker","year":"2006","unstructured":"Pritzker KPH, Gay S, Jimenez SA, et al. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthr Cartilage. 2006;14(1):13\u201329.","journal-title":"Osteoarthr Cartilage"},{"issue":"3","key":"4516_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci.insight.96308","volume":"3","author":"C Lietman","year":"2018","unstructured":"Lietman C, Lechner WB, Rossomacha E. Inhibition of Wnt\/\u03b2-catenin signaling ameliorates osteoarthritis in a murine model of experimental osteoarthritis. JCI Insight. 2018;3(3):1\u201316.","journal-title":"JCI Insight"},{"issue":"1","key":"4516_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar4133","volume":"15","author":"M Wang","year":"2013","unstructured":"Wang M, Hongting J, Sampson ER. MMP13 is a critical target gene during the progression of osteoarthritis. Arthritis Res Ther. 2013;15(1):1\u201311.","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"4516_CR18","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1080\/14737159.2019.1646641","volume":"19","author":"A Mobasheri","year":"2019","unstructured":"Mobasheri A, Lambert C, Henrotin Y. Coll2-1 and Coll2-1NO2 as exemplars of collagen extracellular matrix turnover - biomarkers to facilitate the treatment of osteoarthritis? Expert Rev Mol Diagn. 2019;19(9):803\u201312.","journal-title":"Expert Rev Mol Diagn"},{"issue":"6592","key":"4516_CR19","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/382638a0","volume":"382","author":"J Behrens","year":"1996","unstructured":"Behrens J, Von Kries JP. Functional interaction of b-catenin with the transcription factor LEF-1. Nature. 1996;382(6592):638\u201342.","journal-title":"Nature"},{"issue":"4","key":"4516_CR20","first-page":"1","volume":"12","author":"C Jamieson","year":"2014","unstructured":"Jamieson C, Sharma M, Henderson BR. Targeting the \u03b2-catenin nuclear transport pathway in cancer. Semin Cancer Biol. 2014;12(4):1\u201310.","journal-title":"Semin Cancer Biol"},{"issue":"822","key":"4516_CR21","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1101\/gad.8.22.2691","volume":"22","author":"C Van Genderen","year":"1994","unstructured":"Van Genderen C, Isabel RMO. Development of several oreans that require inductive epithelial-mesenchymal interactions is impaired in LEF-1- deficient mice. Gene Dev. 1994;22(822):2691\u2013703.","journal-title":"Gene Dev"},{"issue":"9","key":"4516_CR22","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.joca.2007.03.006","volume":"15","author":"G Ss","year":"2007","unstructured":"Ss G, Tj B, Ea M. The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129\/SvEv mouse. Osteoarthr Cartilage. 2007;15(9):1061\u20139.","journal-title":"Osteoarthr Cartilage"},{"issue":"5","key":"4516_CR23","first-page":"1","volume":"9","author":"X Fan","year":"2021","unstructured":"Fan X, Wu X, Crawford R, Xiao Y, Prasadam I. Macro, micro, and molecular. Changes of the osteochondral interface in osteoarthritis development. Front Cell Dev Biol. 2021;9(5):1\u201317.","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"4516_CR24","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jbspin.2015.10.004","volume":"83","author":"AOCK Gabay","year":"2016","unstructured":"Gabay AOCK. Epigenetics of cartilage diseases. Joint Bone Spine. 2016;83(5):491\u20134.","journal-title":"Joint Bone Spine"},{"issue":"1","key":"4516_CR25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/abbs\/gms108","volume":"45","author":"X Li","year":"2012","unstructured":"Li X. SIRT1 and energy metabolism. Acta Bioch Bioph Sin. 2012;45(1):51\u201360.","journal-title":"Acta Bioch Bioph Sin"},{"issue":"6","key":"4516_CR26","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.jbspin.2013.01.001","volume":"80","author":"O Gabay","year":"2013","unstructured":"Gabay O, Zaal KJ, Sanchez C, et al. Sirt1-deficient mice exhibit an altered cartilage phenotype. Joint Bone Spine. 2013;80(6):613\u201320.","journal-title":"Joint Bone Spine"},{"key":"4516_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41420-020-0277-0","volume":"6","author":"PK Sacitharan","year":"2020","unstructured":"Sacitharan PK, Bou-Gharios G, Edwards JR. SIRT1 directly activates autophagy in human chondrocytes. Cell Death Discov. 2020;6:41.","journal-title":"Cell Death Discov"},{"issue":"273","key":"4516_CR28","first-page":"345","volume":"2","author":"JA Funka","year":"2013","unstructured":"Funka JA, Schnellmann RG. Accelerated recovery of renal mitochondrial and tubule homeostasis with SIRT1\/PGC-1 \u03b1 activation following ischemia- reperfusion injury. NIH Public Access. 2013;2(273):345\u201354.","journal-title":"NIH Public Access"},{"key":"4516_CR29","first-page":"1","volume":"14","author":"Q Yang","year":"2020","unstructured":"Yang Q, Zhou Y, Sun Y. Will sirtuins be promising therapeutic targets for TBI and associated neurodegenerative diseases? Front Neurosci-Switz. 2020;14:1\u201315.","journal-title":"Front Neurosci-Switz"},{"issue":"18610","key":"4516_CR30","first-page":"1","volume":"10","author":"H Mohammad","year":"2016","unstructured":"Mohammad H, Makki S. Histone deacetylase inhibitor vorinostat (SAHA) suppresses IL-1beInduced matrix metallopeptidase-13 expression by inhibiting IL-6 in osteoarthritis chondrocyte. Am J Pathol. 2016;10(18610):1\u20138.","journal-title":"Am J Pathol"},{"issue":"143","key":"4516_CR31","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.3892\/mmr.2016.5523","volume":"3","author":"H Qu","year":"2016","unstructured":"Qu H, Li J, Wu L. Trichostatin A increases the TIMP-1\/MMP ratio to protect against osteoarthritis in an animal model of the disease. Mol Med Rep. 2016;3(143):2423\u201330.","journal-title":"Mol Med Rep"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-021-04516-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-021-04516-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-021-04516-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T19:10:43Z","timestamp":1627413043000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-021-04516-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,27]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4516"],"URL":"https:\/\/doi.org\/10.1186\/s12891-021-04516-x","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,27]]},"assertion":[{"value":"21 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments were approved by the Animal Experiment Ethics Committee of Ningxia Medical University (protocol number: 2019\u2013066) and approved by the Medical Research Ethics Review Committee of the General Hospital of Ningxia Medical University (Proposal Number: 2020\u2013999). All experiments were carried out under the standard principles of animal experiment ethics and comply with the Declaration of Helsinki. Informed consent has been obtained from all patients, and the purpose and principles of the study, as well as precautions, have been briefed to the patients or their family members, so that they have a detailed understanding of the study at the time of signing the consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from each patient to authorize the publication of their data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"642"}}